These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 15050574

  • 1. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
    Carbon M, Ma Y, Barnes A, Dhawan V, Chaly T, Ghilardi MF, Eidelberg D.
    Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
    [Abstract] [Full Text] [Related]

  • 2. Imaging in Parkinson's disease: the role of monoamines in behavior.
    Brooks DJ, Piccini P.
    Biol Psychiatry; 2006 May 15; 59(10):908-18. PubMed ID: 16581032
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
    Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO.
    Synapse; 2003 Jun 01; 48(3):109-15. PubMed ID: 12645035
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.
    Hsiao MC, Lin KJ, Liu CY, Tzen KY, Yen TC.
    Schizophr Res; 2003 Dec 01; 65(1):39-46. PubMed ID: 14623373
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study.
    Ma Y, Dhawan V, Mentis M, Chaly T, Spetsieris PG, Eidelberg D.
    Synapse; 2002 Aug 01; 45(2):125-33. PubMed ID: 12112405
    [Abstract] [Full Text] [Related]

  • 14. [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.
    Marek K, Innis R, van Dyck C, Fussell B, Early M, Eberly S, Oakes D, Seibyl J.
    Neurology; 2001 Dec 11; 57(11):2089-94. PubMed ID: 11739831
    [Abstract] [Full Text] [Related]

  • 15. Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
    Nurmi E, Ruottinen HM, Kaasinen V, Bergman J, Haaparanta M, Solin O, Rinne JO.
    Ann Neurol; 2000 Jun 11; 47(6):804-8. PubMed ID: 10852547
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
    Vriend C, Raijmakers P, Veltman DJ, van Dijk KD, van der Werf YD, Foncke EM, Smit JH, Berendse HW, van den Heuvel OA.
    J Neurol Neurosurg Psychiatry; 2014 Feb 11; 85(2):159-64. PubMed ID: 23813742
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Antonini A, Benti R, De Notaris R, Tesei S, Zecchinelli A, Sacilotto G, Meucci N, Canesi M, Mariani C, Pezzoli G, Gerundini P.
    Neurol Sci; 2003 Oct 11; 24(3):149-50. PubMed ID: 14598060
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.